Posted by Michael Wonder on 13 Oct 2016
Patients to get faster access to the most cost effective treatments under proposed changes to NICE's process
13 October 2016 - Patients could benefit from the most cost effective treatments nearly three months faster under plans unveiled by NICE and NHS England.
The proposals are part of a joint consultation by NICE and NHS England that would see the introduction of a ‘fast track’ option for appraising technologies which offer exceptional value for money.
This would mean treatments that are likely to have a cost per QALY (quality adjusted life year) of up to £10,000 would be dealt with more quickly under a ‘lighter touch’ process
Sir Andrew Dillon, NICE chief executive, said: “We want to be more agile and flexible in the way we make decisions about new drugs, medical devices and diagnostics, so that patients can get access to them more quickly and the NHS can manage its resources fairly and efficiently. NICE and NHS England have worked together to develop these proposals.
